Anthem (ANTM) PT Raised to $305 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Anthem (ANTM) Tops Q4 EPS by 25c, Miss on Revenues; Offers FY19 EPS/Revenue Guidance Above Consensus
January 30, 2019 6:02 AM ESTAnthem (NYSE: ANTM) reported Q4 EPS of $2.44, $0.25 better than the analyst estimate of $2.19. Revenue for the quarter came in at $23.373 billion versus the consensus estimate of $23.38 billion.
Fourth quarter net income was $1.61 per share, including net negative adjustment items of $0.83 per share. Adjusted net income was $2.44 per share.Full year net income was $14.19 per share, including net negative adjustment items of $1.70 per share. Adjusted net income was $15.89 per share.Medical enrollment increased by 37 thousand members sequentially to 39.9 million members.Operating gain grew by 30% year-over-year to $5.4 billion in... More